http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108452300-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55588
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145
filingDate 2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108452300-B
titleOfInvention Avian influenza inactivated vaccine adjuvant
abstract The invention relates to an avian influenza inactivated vaccine adjuvant and an industrialized preparation method thereof, wherein the adjuvant is obtained by industrially extracting fig leaves by adopting a water-alcohol mixed extraction method, and the extract is used according to a certain concentration and avian influenza inactivated antigen ratio; the invention has the beneficial effects that: the avian influenza inactivated vaccine adjuvant has the advantages of simple preparation process, high safety, low cost, easy storage, convenient use, good effect, no toxic or side reaction, huge development and utilization potential in animal husbandry and wide application prospect.
priorityDate 2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID405790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2355
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522477
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449517
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425194923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546216
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109644000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499243
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416192967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520774
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2782115

Total number of triples: 51.